Literature DB >> 22772317

Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis.

Carolin Hauenstein1, Matthias Reinhard, Julia Geiger, Michael Markl, Andreas Hetzel, Andras Treszl, Peter Vaith, Thorsten A Bley.   

Abstract

OBJECTIVE: To compare the impact of initial corticosteroid treatment on high-resolution MRI and colour-coded duplex sonography (CCDS) findings in patients with GCA (temporal).
METHODS: Sensitivity and specificity of CCDS and high-resolution contrast-enhanced MRI studies of 59 patients with suspected GCA were retrospectively analysed. Patients were grouped according to the duration of steroid treatment before imaging: 0-1 day, 2-4 days and >4 days. In 41 patients, imaging results were compared with findings of temporal artery biopsy (TAB).
RESULTS: Sixty-one per cent (36/59) of patients were diagnosed with GCA. TAB findings were positive in 59% (24/41). The compared results of TAB sensitivity of CCDS and MRI under steroid treatment of 0-1 day were 92% and 90%, 2-4 days 80% and 78% and >4 days 50% and 80%, respectively. The compared results of the final clinical diagnosis sensitivity of CCDS and MRI under steroid treatment of 0-1 day was 88% and 85%, 2-4 days 50% and 64% and >4 days 50% and 56%, respectively.
CONCLUSION: Sensitivity of a first-time CCDS or an MRI for detection of GCA rapidly decreases under corticosteroid treatment. Therefore imaging of patients with suspected GCA should be performed as soon as possible, preferably within the first days of treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22772317     DOI: 10.1093/rheumatology/kes153

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  33 in total

Review 1.  Role of ultrasound in the understanding and management of vasculitis.

Authors:  Wolfgang A Schmidt
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-04       Impact factor: 5.346

Review 2.  The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist.

Authors:  Sara Monti; Alberto Floris; Cristina Ponte; Wolfgang A Schmidt; Andreas P Diamantopoulos; Claudio Pereira; Jennifer Piper; Raashid Luqmani
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

3.  Bilateral axillary arterial obstruction.

Authors:  Beatrice van der Matten; Adrienne Anne Marie Zandbergen; Adriaan Dees
Journal:  BMJ Case Rep       Date:  2014-01-22

Review 4.  Intracranial Vessel Wall MRI: Principles and Expert Consensus Recommendations of the American Society of Neuroradiology.

Authors:  D M Mandell; M Mossa-Basha; Y Qiao; C P Hess; F Hui; C Matouk; M H Johnson; M J A P Daemen; A Vossough; M Edjlali; D Saloner; S A Ansari; B A Wasserman; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-28       Impact factor: 3.825

Review 5.  Giant Cell Arteritis: Practical Pearls and Updates.

Authors:  Swati Pradeep; Jonathan H Smith
Journal:  Curr Pain Headache Rep       Date:  2018-01-17

Review 6.  Clinical practice. Giant-cell arteritis and polymyalgia rheumatica.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 91.245

Review 7.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

Review 8.  [Ultrasound in rheumatology. What's new?].

Authors:  W Hartung; W A Schmidt
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

9.  [Imaging diagnostics in large vessel vasculitis].

Authors:  W A Schmidt; W Hartung
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

10.  MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis.

Authors:  Simon Veldhoen; Thorsten Klink; Julia Geiger; Peter Vaith; Cornelia Glaser; Thomas Ness; Dirk Duwendag; Marcus Both; Thorsten A Bley
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.